Sector News

Arkema acquires sealants producer Den Braven for €485 million

July 20, 2016
Chemical Value Chain

Arkema announced today that it has agreed to acquire the sealants producer Den Braven  from the Dutch private equity firm Egeria in a deal valued at €485 million ($533 million).

The price equals 11x 2016 Ebitda estimate and Arkema envisages annualized synergies of €30 million to be achieved within five years. The acquisition is subject to consultations with Arkema BV’s works council and antitrust approvals. Closing is expected in the last quarter of 2016.

Den Braven, a leading player in high performance sealants in Europe with estimated sales of €350 million this year, will reinforce Bostik, Arkema’s existing adhesives & sealants business. The deal is in line with Arkema’s plans for bolt-on acquisitions in selected areas, including adhesives.

Den Braven employs about 1,000 people and operates eight plants, including two each in Germany and Netherlands as well as plants in France, Romania, Turkey and in the United States. Den Braven offers an extensive range of sealing, bonding and foam solutions for construction professionals as well as industry and reinforces Bostik’s offering in the insulation and construction markets. The geographic and technological fit will help create a global leader in the high performance sealants market, which is growing at 3-4%/year, Arkema says.

Bostik although a leading player has a share of only about 3-4% of the global adhesives & sealants market, which is very fragmented. Globally, the market is estimated at about €50 billion/year of which sealants account for €9 billion/year. The acquisition is in line with Arkema’s plan to increase the share of its high performance materials (HPM) segment, which should account for 50% of group sales by 2020. In addition to Bostik, HPM includes technical polymers, filtration and adsorption and organic peroxides.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

October 23, 2021

INEOS to take leading role in the hydrogen revolution with launch of hydrogen campaign

Chemical Value Chain

INEOS, Europe’s biggest operator of electrolysis needed to produce clean, low carbon hydrogen, has doubled down on its €2 billion investment in green hydrogen with the launch of a hydrogen advocacy campaign. The campaign kicked off with the publication of a powerful editorial in the Sunday Telegraph on the hydrogen economy written by Sir Jim Ratcliffe, INEOS’s founder and chairman.

October 23, 2021

Vertellus completes acquisition of IM Chemicals

Chemical Value Chain

Vertellus, a manufacturer of specialty products for consumer goods, food & agriculture, healthcare, and industrial markets, today announced the completion of its acquisition of IM Chemicals. With the addition of IM Chemicals, Vertellus expands its specialty ingredients portfolio into new markets and bolsters its manufacturing capabilities in Europe.

October 23, 2021

Johnson Matthey announces research project aimed at catalytic reduction if dairy methane emissions

Chemical Value Chain

A new collaboration between scientists, engineers, industry and farming experts hopes to demonstrate how clever technology can reduce the powerful greenhouse gases released by livestock to help agriculture reach carbon emissions targets.

Send this to a friend